PHATHOM PHARMACEUTICALS INC's ticker is PHAT and the CUSIP is 71722W107. A total of 88 filers reported holding PHATHOM PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 1.42 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,436,245 | -35.2% | 138,500 | -10.5% | 0.00% | – |
| Q2 2023 | $2,214,846 | +537.2% | 154,668 | +217.7% | 0.00% | – |
| Q1 2023 | $347,583 | -58.1% | 48,681 | -34.2% | 0.00% | – |
| Q4 2022 | $830,414 | +30.8% | 74,012 | +29.1% | 0.00% | – |
| Q3 2022 | $635,000 | +43.7% | 57,342 | +9.5% | 0.00% | – |
| Q2 2022 | $442,000 | +14.5% | 52,372 | +84.8% | 0.00% | – |
| Q1 2022 | $386,000 | -42.5% | 28,337 | -16.9% | 0.00% | – |
| Q4 2021 | $671,000 | +191.7% | 34,117 | +376.3% | 0.00% | – |
| Q3 2021 | $230,000 | -84.3% | 7,163 | -83.7% | 0.00% | – |
| Q4 2020 | $1,464,000 | +624.8% | 44,078 | +579.0% | 0.00% | – |
| Q4 2019 | $202,000 | – | 6,492 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 2,484,274 | $27,873,554 | 11.71% |
| Frazier Life Sciences Management, L.P. | 8,407,152 | $94,328,245 | 5.86% |
| Abingworth LLP | 1,435,106 | $16,101,889 | 5.25% |
| Opaleye Management Inc. | 417,500 | $4,684,350 | 1.63% |
| 683 Capital Management, LLC | 1,350,000 | $15,147,000 | 1.28% |
| Newtyn Management, LLC | 484,074 | $5,431,310 | 1.12% |
| Penn Mutual Asset Management | 62,802 | $704,638 | 0.79% |
| StepStone Group LP | 422,085 | $4,735,794 | 0.62% |
| MPM BioImpact LLC | 195,942 | $2,198,469 | 0.57% |
| Avidity Partners Management LP | 1,900,000 | $21,318,000 | 0.46% |